GPC
biotech About
GPC biotech GPC
Biotech AG is a biotechnology company discovering and developing new anticancer
drugs. The Company's lead product candidate - satraplatin - is currently
in a Phase 3 registration trial as a second-line chemotherapy treatment in hormone-refractory
prostate cancer Other anticancer programs in development include a monoclonal
antibody and a cell cycle inhibitor. Satraplatin 1D09C3
Anticancer Monoclonal Antibody dk Inhibitors
GPC
Biotech